CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Option exercise Director acquired 4,804 shares (option exercise)
- 4 Open-market sale Director sold 50,000 shares at $26.03 ($1,301,505)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Head of U.S. Commercial sold 28,229 shares at $24.78 ($699,523)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Head of U.S. Commercial sold 30,000 shares at $25.11 ($753,321)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 200,000 shares at $24.11 ($4,821,880)
- 4 Open-market sale Chief Accounting Officer sold 12,300 shares at $24.44 ($300,564)
- 144/A Insider Sale of Securities
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Open-market buy EVP, Chief Legal Officer bought 1,113 shares at $18.86 ($20,988)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale See "Remarks" sold 6,053 shares at $15.16 ($91,748)
- 4 Planned sale See "Remarks" sold 52,742 shares at $15.16 ($799,437)
- 144 Insider Sale of Securities
Page 9 of 128 · 2,555 filings